Recombinant Human SEMG1 (C-6His)

Description

EnkiLife provides the Recombinant Human SEMG1 (C-6His) protein,aslo know as Semenogelin-1,Semenogelin I,SGI,SEMG1,SEMG,Alpha-Inhibin-92,Alpha-Inhibin-31,Seminal Basic Protein, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Semenogelin-1 is produced by our Mammalian expression system and the target gene encoding Gln24-Thr402 is expressed with a 6His tag at the C-terminus.Accession:AAH07096.1. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:43.8 KDa. Background:Semenogelin-1 (SEMG1) is the predominant protein in semen; it is a secretory protein involved in the formation of a gel matrix entrapping the accessory gland secretions and ejaculated spermatozoa. The prostate-specific antigen (PSA) protease processes SEMG1 into smaller peptides, each possibly having a separate function. In the proteolysis process, Alpha-inhibin-92 and alpha-inhibin-31 are produced; they inhibit the secretion of pituitary follicle-stimulating hormone. At the same time, it breaks down the gel matrix, allowing the spermatozoa to move more freely.